← Leaderboards
Monica T Pupo
Harvard Medical School
$1,738,499
Attributed
$1,738,499
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2014–18$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,097,767 · 2
By mechanism
U19$6,097,767 · 2
Top collaborators
- Jon Clardy6 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Marc W Kirschner$55,400,682
- Ulrich H Von Andrian$44,950,919
- Radhika Nagpal$619,731
- Jeffrey Scott Turner$619,731
- Justin K Werfel$619,731
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsNovel TherapeuticsParasitesLaboratoriesMetabolomicsMycosesGenotypeLeishmaniasisHigh Throughput ScreeningInvertebratesCatalogsMalignant NeoplasmsChagas DiseaseMicrobialBaseCountryFractionationDrug DiscoveryAnimalsBiodiversityBrazilInsectaAntsPharmacologic Substance
Grant awards (11)
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$798,694
U19 · FY2018 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$349,953
U19 · FY2018 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$150,000
U19 · FY2018 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$819,421
U19 · FY2017 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$361,650
U19 · FY2017 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$831,606
U19 · FY2016 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$364,805
U19 · FY2016 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$852,523
U19 · FY2015 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$343,707
U19 · FY2015 · TW · contact PI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$907,024
U19 · FY2014 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates$318,384
U19 · FY2014 · TW · contact PI